世界の抗体薬物複合体（ADC）受託製造市場規模は、2028年までに184億米ドルに達する見込みです。この市場は、2021年から2028年にかけて12.3%のCAGRで拡大すると予測されています。市場拡大の要因は、抗体薬物複合体（ADC）の複雑な性質、製造能力に対する需要の増加、および抗体療法に関する研究の増加です。
ADCプロジェクトの約70.0%が開発・製造受託機関に委託されています。ADCは複雑な分子であるため、安全に取り扱うためには生物学的クリーンルームや細胞毒性の高い施設が必要となります。したがって、熟練した労働者を必要とする特殊で革新的な化学物質を提供できる企業には大きなチャンスがあります。
現在、ADCはニッチな市場であり、すべての成分を提供しているCMOは少なく、複雑なサプライチェーンが発生しています。その上、商業的に認可されたADCは7種類で、約90のプロジェクトが臨床試験中であるため、生産効率を上げるためには、複雑なサプライチェーンを削減することが不可欠である。治験を成功させるためには、透明性のある統合されたサプライチェーンが不可欠である。
コロナウイルスのパンデミックにより、モノクローナル抗体開発に対する通常は楽観的で慎重なアプローチが評価され、1年前に最も有望とされた抗体だけでなく、COVID-19治療薬として注目された他の抗体薬物複合体のサプライチェーンも混乱させられました。COVID-19パンデミックの発生により、政府や産業界の科学者たちは医薬品やワクチンの開発に向けて強力かつ迅速な反応を示しています。効果的なCOVID-19治療薬の需要が高まっていることから、ワクチン、抗体薬物複合体、その他の医薬品の世界的な生産が拡大すると予測されています。
目次
Table of Contents
Chapter 1 Report Scope
1.1 Segment Scope
1.2 Regional Scope
Chapter 2 Methodology
2.1 Research Methodology
2.1.1 Information Procurement
2.2 Information Or Data Analysis
2.3 Market Formulation & Validation
2.4 Region Wise Market Calculation
2.4.1 Approaches Used To Estimate The Market Size
2.4.1.1 Approach 1: Region Wise Market Estimation Using Bottom-Up Approach
2.4.1.2 Approach 2: Parent Market Analysis
2.4.1.3 Approach 3: Commodity Flow
2.4.2 Global Market: Cagr Calculation
2.5 Model Details
2.5.1 Commodity Flow Analysis (Model 1)
2.6 List of Secondary Sources
2.7 List of Primary Sources
2.8 List of Abbreviations
Chapter 3 Objectives
3.1 Objective - 1: Understanding the market dynamics
3.2 Objective - 2: Understanding the market estimates and forecasts
3.3 Objective - 3: Understanding the attributes such as strategy framework, competitor categorization
3.4 Objective - 4: Understanding the key service and application scopes to conclude on the market size.
Chapter 4 Executive Summary
4.1 Market Outlook
4.2 Segment Outlook
4.3 Competitive Insights
Chapter 5 Antibody drug conjugates contract manufacturing market: Variables, Trends & Scope
5.1 Market Lineage Outlook
5.1.1 Parent Market Outlook
5.1.2 Ancillary Market Outlook
5.2 Penetration & Growth Prospect Mapping
5.3 Market Variable Analysis
5.3.1 Market Driver Analysis
5.3.1.1 Rising Prevalence Of Cancer
5.3.1.2 Advancemtent In Medical Technology
5.3.1.3 Increasing Demand For The Biologic Therapy
5.3.2 Market Restraint Analysis
5.3.2.1 High Manufacturing Cost Of Antibody Drug Conjugates
5.4 Antibody Drug Conjugates Contract Manufacturing Market: Analysis Tools
5.4.1 Porter’s Five Forces Analysis
5.4.2 Pestel Analysis
5.4.3 Major Deals & Strategic Alliances Analysis
Chapter 6 Antibody drug conjugates contract manufacturing market: Condition Segment Analysis
6.1 Antibody drug conjugates contract manufacturing market : Definition & Scope
6.2 Antibody drug conjugates contract manufacturing market: Market Share Analysis, 2020 & 2028
6.3 Myeloma
6.3.1 Myeloma Market, 2016 - 2028 (USD Million)
6.3.2 Lymphoma
6.3.2.1 Lymphoma Market, 2016 - 2028 (USD Million)
6.3.3 Breast Cancer
6.3.3.1 Breast Cancer Market, 2016 - 2028 (USD Million)
6.3.4 Others (Urothelial Cancer)
6.3.4.1 Others (Urothelial Cancer) Market, 2016 - 2028 (USD Million)
Chapter 7 Antibody drug conjugates contract manufacturing market : Linker Segment Analysis
7.1 Antibody drug conjugates contract manufacturing market: Definition & Scope
7.2 Antibody drug conjugates contract manufacturing market: Market Share Analysis, 2020 & 2028
7.3 Cleavable Linker
7.3.1 Cleavable Linker Market, 2016 - 2028 (USD Million)
7.4 Non-cleavable Linker
7.4.1 Non-cleavable Linker Market, 2016 - 2028 (USD Million)
Chapter 8 Antibody drug conjugates contract manufacturing market: Regional Analysis
8.1 Antibody drug conjugates contract manufacturing market: Definition & Scope
8.2 Regional Market Snapshot
8.3 Antibody drug conjugates contract manufacturing market: Market Share Analysis, 2020 & 2028
8.4 North America
8.4.1 North America antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.4.2 U.S.
8.4.2.1 U.S. antibody drug conjugates contract manufacturing market , 2016 - 2028 (USD Million)
8.4.3 Canada
8.4.3.1 Canada antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.5 Europe
8.5.1 Europe antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.5.2 France
8.5.2.1 France antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.5.3 U.K.
8.5.3.1 U.K. antibody drug conjugates contract manufacturing market , 2016 - 2028 (USD Million)
8.5.4 Germany
8.5.4.1 Germany antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.5.5 Italy
8.5.5.1 Italy antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.5.6 Spain
8.5.6.1 Spain antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.6 Asia Pacific
8.6.1 Asia pacific antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.6.2 Japan
8.6.2.1 Japan antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.6.3 China
8.6.3.1 China stair lift and climbing devices market, 2016 - 2028 (USD Million)
8.6.4 India
8.6.4.1 India antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.6.5 South Korea
8.6.5.1 South korea antibody drug conjugates contract manufacturing market , 2016 - 2028 (USD Million)
8.6.6 Australia
8.6.61 Australia antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.7 Latin America
8.7.1 Latin america antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.7.2 Brazil
8.7.2.1 Brazil antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.7.3 Mexico
8.7.3.1 Mexico antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.7.4 Argentina
8.7.4.1 Argentina antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.8 MEA
8.8.1 MEA antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.8.2 South Africa
8.8.2.1 South Africa antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.8.3 Saudi Arabia
8.8.3.1 Saudi Arabia antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
8.8.4 UAE
8.8.4.1 UAE antibody drug conjugates contract manufacturing market, 2016 - 2028 (USD Million)
Chapter 9 Company Profiles
9.1 Cambrex
9.1.1 Company Overview
9.1.2 Financial Performance
9.1.3 Service Benchmarking
9.1.4 Strategic Initiatives
9.2 ReciPharm
9.2.1 Company Overview
9.2.2 Service Benchmarking
9.2.3 Strategic Initiatives
9.3 ThermoFisher
9.3.1 Company Overview
9.3.2 Financial Performance
9.3.3 Service Benchmarking
9.3.4 Strategic Initiatives
9.4 Pantheon
9.4.1 Company Overview
9.4.2 Financial Performance
9.4.3 Service Benchmarking
9.4.4 Strategic Initiatives
9.5 Corden Pharma
9.5.1 Company Overview
9.5.2 Financial Performance
9.5.3 Service Benchmarking
9.5.4 Strategic Initiatives
9.6 Samsung Biologics
9.6.1 Company Overview
9.6.2 Financial Performance
9.6.3 Service Benchmarking
9.6.4 Strategic Initiatives
9.7 Lonza
9.7.1 Company Overview
9.7.2 Financial Performance
9.7.3 Service Benchmarking
9.7.4 Strategic Initiatives
9.8 Catalent
9.8.1 Company Overview
9.8.2 Financial Performance
9.8.3 Service Benchmarking
9.9 Siegfried
9.9.1 Company Overview
9.9.2 Financial Performance
9.9.3 Service Benchmarking
9.9.4 Strategic Initiatives
9.10 Piramal Pharma Solutions
9.10.1 Company Overview
9.10.2 Service Benchmarking
9.10.3 Strategic Initiatives
9.11 Boehringer Ingelheim
9.11.1 Company Overview
9.11.2 Service Benchmarking
9.11.3 Strategic Initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 List of Secondary Sources
Table 3 Global antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 4 Global antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 5 Global antibody drug conjugates contract manufacturing market, by region, 2016 - 2028 (USD Million)
Table 6 North America Antibody drug conjugates contract manufacturing market, by region, 2016 - 2028 (USD Million)
Table 7 North America Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 8 North America Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 9 U.S. Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 10 U.S. Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 11 Canada Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 12 Canada Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 13 Europe Antibody drug conjugates contract manufacturing market, by region, 2016 - 2028 (USD Million)
Table 14 Europe Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 15 Europe Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 16 U.K. Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 17 U.K. Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 18 Germany Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 19 Germany Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 20 Spain Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 21 Spain Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 22 France Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 23 France Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 24 Italy Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 25 Italy Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 26 Asia Pacific Antibody drug conjugates contract manufacturing market, by region, 2016 - 2028 (USD Million)
Table 27 Asia Pacific Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 28 Asia Pacific Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 29 China Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 30 China Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 31 India Antibody drug conjugates contract manufacturing market, by condition, (USD Million) 2016 - 2028 (USD Million)
Table 32 India Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 33 Japan Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 34 Japan Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 35 Australia Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 36 Australia Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 37 South Korea Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 38 South Korea Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 39 Latin America Antibody drug conjugates contract manufacturing market, by region, 2016 - 2028 (USD Million)
Table 40 Latin America Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 41 Latin America Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 42 Brazil Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 43 Brazil Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 44 Mexico Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 45 Mexico Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 46 Argentina Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 47 Argentina Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 48 MEA Antibody drug conjugates contract manufacturing market, by region, 2016 - 2028 (USD Million)
Table 49 MEA Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 50 MEA Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 51 South Africa Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 52 South Africa Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 53 Saudi Arabia Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 54 Saudi Arabia Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
Table 55 UAE Antibody drug conjugates contract manufacturing market, by condition, 2016 - 2028 (USD Million)
Table 56 UAE Antibody drug conjugates contract manufacturing market, by linker, 2016 - 2028 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Commodity Flow Analysis
Fig. 8 Antibody drug conjugates contract manufacturing market snapshot (2020)
Fig. 9 Antibody drug conjugates contract manufacturing market segmentation
Fig. 10 Antibody drug conjugates contract manufacturing market: Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Antibody drug conjugates contract manufacturing market: Component movement analysis
Fig. 19 Antibody drug conjugates contract manufacturing market condition outlook: Segment Dashboard
Fig. 20 Antibody drug conjugates contract manufacturing market: Condition movement analysis
Fig. 21 Myeloma market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 22 Lymphoma market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 23 Breast cancer market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 24 Others (urothelial cancer) market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 25 Antibody drug conjugates contract manufacturing market linker outlook: Segment Dashboard
Fig. 26 Antibody drug conjugates contract manufacturing market: Linker movement analysis
Fig. 27 Cleavable linker market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 28 Non-cleavable linker market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 29 Regional market place: Dashboard
Fig. 30 Antibody drug conjugates contract manufacturing market: Definition & Scope
Fig. 31 Regional Market Snapshot (Figures in USD Billion, 2018)
Fig. 32 Regional outlook, 2020 & 2028
Fig. 33 North America market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 34 U.S. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 35 Canada market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 36 Europe market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 37 France market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 38 U.K. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 39 Germany market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 40 Italy market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 41 Spain market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 42 Asia Pacific market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 43 Japan market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 44 China market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 45 India market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 46 South Korea market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 47 Australia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 48 Latin America market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 49 Brazil market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 50 Mexico market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 51 Argentina market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 52 MEA market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 53 South Africa market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 54 Saudi Arabia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 55 UAE market estimates and forecast, 2016 - 2028 (USD Million)
